D.E. Shaw & Co’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.59M | Buy |
575,624
+138,225
| +32% | +$552K | ﹤0.01% | 2715 |
|
|
2025
Q4 | $1.67M | Buy |
+437,399
| New | +$1.7M | ﹤0.01% | 3193 |
|
|
2024
Q4 | – | Sell |
-16,122
| Closed | -$106K | – | 4660 |
|
|
2024
Q3 | $106K | Buy |
+16,122
| New | +$130K | ﹤0.01% | 4245 |
|
|
2019
Q4 | – | Sell |
-20,322
| Closed | -$180K | – | 4078 |
|
|
2019
Q3 | $180K | Buy |
20,322
+11,890
| +141% | +$130K | ﹤0.01% | 3642 |
|
|
2019
Q2 | $121K | Sell |
8,432
-2,552
| -23% | -$68K | ﹤0.01% | 3532 |
|
|
2019
Q1 | $361K | Sell |
10,984
-1,436
| -12% | -$73.6K | ﹤0.01% | 3139 |
|
|
2018
Q4 | $738K | Sell |
12,420
-9,488
| -43% | -$937K | ﹤0.01% | 2861 |
|
|
2018
Q3 | $3.07M | Sell |
21,908
-7,105
| -24% | -$862K | ﹤0.01% | 1902 |
|
|
2018
Q2 | $3.56M | Sell |
29,013
-3,779
| -12% | -$321K | ﹤0.01% | 1777 |
|
|
2018
Q1 | $2.93M | Sell |
32,792
-3,251
| -9% | -$276K | ﹤0.01% | 1765 |
|
|
2017
Q4 | $2M | Sell |
36,043
-3,343
| -8% | -$151K | ﹤0.01% | 2143 |
|
|
2017
Q3 | $1.66M | Buy |
39,386
+2,407
| +7% | +$100K | ﹤0.01% | 2161 |
|
|
2017
Q2 | $1.56M | Sell |
36,979
-5,328
| -13% | -$272K | ﹤0.01% | 2135 |
|
|
2017
Q1 | $2.37M | Buy |
42,307
+4,604
| +12% | +$229K | ﹤0.01% | 1733 |
|
|
2016
Q4 | $1.44M | Buy |
37,703
+6,513
| +21% | +$264K | ﹤0.01% | 2245 |
|
|
2016
Q3 | $1.24M | Sell |
31,190
-3,835
| -11% | -$174K | ﹤0.01% | 2258 |
|
|
2016
Q2 | $2.52M | Buy |
35,025
+7,069
| +25% | +$559K | ﹤0.01% | 1761 |
|
|
2016
Q1 | $2.24M | Buy |
+27,956
| New | +$2.21M | ﹤0.01% | 1803 |
|
|
2015
Q3 | – | Sell |
-731
| Closed | -$304K | – | 3819 |
|
|
2015
Q2 | $304K | Buy |
+731
| New | +$306K | ﹤0.01% | 3411 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC